Alexion Pharmaceuticals Inc. and Oncology Care Live Release: Diagnosis and Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) to be Presented Live Online Via Video at Oncology Care Live April 27th

BOSTON, April 5, 2011 (GLOBE NEWSWIRE) -- Oncology Care Live (www.OncologyCarelive.com), the live online oncology congress, today announced that Michael J. Borowitz, M.D., Ph.D., and Robert A. Brodsky, M.D., both of Johns Hopkins University School of Medicine, will be presenting live online via video on Wednesday April 27th on the diagnosis and treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Attendees will be able to garner real-time answer to their questions to presenting faculty. Paroxysmal Nocturnal Hemoglobinuria, also sometimes referred to as Marchiafava-Micheli syndrome, is rare, occurring in only 1-2 persons per million. PNH may go undiagnosed because some symptoms of PNH may also be symptoms of other bone marrow diseases and because the disease may not at first be suspected given its rarity. Early diagnosis is vital, given the life-threatening and progressive nature of the disease. PNH is characterized by complement-induced intravascular hemolytic anemia (anemia due to destruction of red blood cells in the bloodstream), red urine (due to the appearance of hemoglobin in the urine) and thrombosis.

MORE ON THIS TOPIC